Free Trial
→ Wall Street legend reveals his top AI stock before Oct. 20 (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:ALVOW

Alvotech Earnings Date & Estimates

Alvotech logo
$0.45 0.00 (0.00%)
As of 10/13/2026

Alvotech is estimated to report earnings on Wednesday, November 11, 2026, after market closes.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Alvotech

Alvotech is expected to post earnings of -$0.0186 per share on revenue of $139.22 million.

Consensus Estimates

Consensus EPS
-$0.0186
Expected Revenue
$139.22 million

Prepare for the Earnings Call

Alvotech Earnings FAQ

Alvotech (NASDAQ:ALVOW) is estimated to report earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Alvotech to post earnings of -$0.0186 per share for the quarter.

The consensus revenue estimate for Alvotech is $139.22 million for the quarter.

Alvotech Earnings Headlines

Alvotech Submits First Known Biosimilar Application For Eylea 8 Mg With Advanz Pharma
 |  rttnews.comhttps://www.rttnews.com/3698859/alvotech-submits-first-known-biosimilar-application-for-eylea-8-mg-with-advanz-pharma.aspx
Alvotech, Advanz Pharma File First Known Biosimilar Application For Eylea 8mg
 |  rttnews.comhttps://www.rttnews.com/3698870/alvotech-advanz-pharma-file-first-known-biosimilar-application-for-eylea-8mg.aspx
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
October 14 at 1:00 AM  |  Profits Run (Ad)
Alvotech (ALVO) Could Be 14% Undervalued On Manufacturing Capacity Updates
October 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alvotech-alvo-could-14-undervalued-111541316.html
Alvotech stock surges after FDA manufacturing approval
October 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/alvotech-stock-surges-fda-manufacturing-152122250.html
Alvotech : FDA approves additional U.S. manufacturing capacity for SIMLANDI, Alvotech's biosimilar to Humira
October 5, 2026  |  marketscreener.comM
See More Alvotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alvotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alvotech and other key companies, straight to your email.

About Alvotech

Alvotech (NASDAQ:ALVOW) is a biopharmaceutical company headquartered in Reykjavik, Iceland, focused on developing and manufacturing biosimilar medicines. Biosimilars are biological products designed to be highly similar to already approved biologic therapies and are intended to expand patient access to complex treatments at potentially lower costs.

The company operates an integrated platform covering cell-line development, process development, analytical testing, clinical development and commercial-scale manufacturing. Its pipeline has included biosimilar candidates in areas such as immunology, ophthalmology, oncology and autoimmune disease, including products targeting therapies with applications in conditions such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.

Alvotech serves international markets through commercial and strategic partnerships with pharmaceutical companies and distributors. Its products and candidates have been developed for markets including the United States, Europe and other regions, with regulatory approvals and commercial availability varying by product and geography. The company was founded in 2013 by Robert Wessman, who has been associated with Alvotech’s leadership as executive chairman.

View Alvotech Profile
Earnings Tools